omega-n-methylarginine has been researched along with Tachyarrhythmia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, T; Gardiner, SM; Kemp, PA; March, JE | 1 |
| Egashira, K; Hirakawa, Y; Katsuda, Y; Kubota, T; Kuga, T; Mohri, M; Tagawa, T; Takeshita, A | 1 |
| Egashira, K; Mohri, M; Tagawa, H; Takeshita, A | 1 |
| Arimura, K; Egashira, K; Ide, T; Machida, Y; Nakamura, R; Shimokawa, H; Takeshita, A; Tsutsui, H | 1 |
4 other study(ies) available for omega-n-methylarginine and Tachyarrhythmia
| Article | Year |
|---|---|
Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats.
Topics: Animals; Arginine; Cardiac Output; Disease Models, Animal; Enzyme Induction; Hemodynamics; Hypotension; Lipopolysaccharides; Lung; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Reproducibility of Results; Stroke Volume; Tachycardia | 1995 |
Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans.
Topics: Acetylcholine; Adult; Aged; Cardiac Pacing, Artificial; Coronary Circulation; Coronary Disease; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Risk Factors; Tachycardia; Vasodilation; Vasomotor System | 1996 |
Intracoronary enalaprilat improves metabolic coronary vasodilation in patients with idiopathic dilated cardiomyopathy.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Coronary Vessels; Drug Interactions; Enalaprilat; Enzyme Inhibitors; Female; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Tachycardia; Vasodilation; Vasodilator Agents | 2000 |
Increased inactivation of nitric oxide is involved in impaired coronary flow reserve in heart failure.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Adenosine; Animals; Coronary Circulation; Dogs; Echocardiography; Endothelium, Vascular; Enzyme Inhibitors; Heart Failure; Hyperemia; Immunohistochemistry; Indicators and Reagents; Lipid Peroxidation; Myocardium; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Pacemaker, Artificial; Reactive Oxygen Species; Tachycardia; Vasodilator Agents | 2001 |